Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Nutritional Support During Induction Therapy for Esophageal Cancer

Nutritional Support in Patient Undergoing Induction Therapy for Esophageal Cancer

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Patients diagnosed with esophageal cancer have difficulty eating, as the food pipe becomes obstructed by the cancer. This may impair the ability for the patient to receive appropriate calorie intake, especially during administration of chemotherapy and radiation therapy given prior to surgical resection. A strategy is to place a feeding tube directly in the stomach or in the small bowel to have an access to the patient's gastrointestinal tract during administration of chemo radiation therapy. However, these feeding tubes may lead to adverse events, including dislodgement, infection, the tube may be plugged, etc. If these complications were to happen, patients may have their treatment delayed, may have to come to the emergency department or even be admitted. In some cases, patients may need to have a surgery performed to treat the complication. Most centres in Canada have moved away from placement of these feeding tubes due to the high incidence of complications associated with the feeding tubes placement, and due to the high efficacy from the chemoradiation therapy in shrinking the tumour, allowing for the patient to swallow. In London, the preference from the Medical and Radiation Oncologists was to have these feeding tubes placed to avoid delay in treating the patients. There is therefore significant controversy as to what is the best approach in this patient population. Our goal is to run a feasibility randomized controlled trial studying this question.

Who May Be Eligible (Plain English)

Who May Qualify: - Adult patient - Non-cervical biopsy-proven esophageal or gastroesophageal junction (Siewert I or II) cancer - Patient eligible for induction therapy then esophagectomy (stage Ib to III) Who Should NOT Join This Trial: - Impossibility to pass an endoscope beyond the tumour - metastatic disease - early-stage disease with either upfront esophagectomy or endoscopic resection planned - patient refusal of the feeding tube - inability to swallow their pill - inability to tolerate a full fluid diet Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adult patient * Non-cervical biopsy-proven esophageal or gastroesophageal junction (Siewert I or II) cancer * Patient eligible for induction therapy then esophagectomy (stage Ib to III) Exclusion Criteria: * Impossibility to pass an endoscope beyond the tumour * metastatic disease * early-stage disease with either upfront esophagectomy or endoscopic resection planned * patient refusal of the feeding tube * inability to swallow their pill * inability to tolerate a full fluid diet

Treatments Being Tested

PROCEDURE

No feeding tube placed

The experimental arm will forego placement of a feeding tube.

PROCEDURE

Placement of a percutaneous feeding tube

The standard arm will have a feeding tube placed (G-tube or GJ-tube by IR; or surgically placed J-tube)

Locations (1)

London Health Sciences Centre - Victoria Hospital
London, Ontario, Canada